comparemela.com

Page 3 - Lynparza Olaparib News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca India Gets Approval To Market Drug Treating Breast Cancer

Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer.

Lynparza olaparibGagandeep singhAstrazeneca indiaDrugs controller generalOlympia phaseBreast cancerZeneca india managing directorCountry president gagandeep singhCommunicable diseasesDrug for breast cancer

Improved outcome for prostate cancer patients in Phase III PROpel trial

Lynparza (Olaparib) combination reduced the risk of disease progression or death by 34 percent in the Phase III PROpel trial.

Merck lynparza olaparibLynparza olaparibEliav barrMerck research laboratories

vimarsana © 2020. All Rights Reserved.